financetom
Business
financetom
/
Business
/
China retaliates in global trade war with sweeping tariffs on U.S. goods
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China retaliates in global trade war with sweeping tariffs on U.S. goods
Apr 4, 2025 3:54 AM

BEIJING/BRUSSELS/PARIS (Reuters) - China announced additional tariffs of 34% on U.S. goods on Friday, the most serious escalation in a trade war with President Donald Trump that has fed fears of a recession and triggered a global stock market rout.

Beijing also announced it was adding several U.S. entities to an export control list and classifying others as an "unreliable" entity.

Nations from Canada to China have readied retaliation in an escalating trade war after Trump raised U.S. tariff barriers to their highest level in more than a century this week, leading to a plunge in world financial markets. 

In Japan, one of United States' top trading partners, Prime Minister Shigeru Ishiba said that the tariffs had created a "national crisis" as a plunge in banking shares on Friday set Tokyo's stock market on course for its worst week in years.

Investment bank JP Morgan said it now sees a 60% chance of the global economy entering recession by year end, up from 40% previously.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why NIO Stock Is Falling
Why NIO Stock Is Falling
Dec 10, 2024
Shares of Nio Inc ( NIO ) – ADR are trading lower by 7.34% to $4.80 during Tuesday’s session as broader economic challenges in China weigh on investor sentiment. What Happened: November trade data underscored a deepening slowdown in China's economy, marked by a 3.9% year-over-year slump in imports, reflecting weak domestic consumption and a protracted housing crisis. This is...
Immix Biopharma Gives Update on Clinical Data for Rare Disease Drug Candidate; Shares Lower
Immix Biopharma Gives Update on Clinical Data for Rare Disease Drug Candidate; Shares Lower
Dec 10, 2024
11:09 AM EST, 12/10/2024 (MT Newswires) -- Immix Biopharma ( IMMX ) said Tuesday that updated data for its drug NXC-201 showed a 94% overall response rate in patients with AL amyloidosis. The drug had a complete response rate of 75% in the phase 1b/2 Nexicart-1 study, according to the company. One patient maintained a complete response for 31.5 months,...
Microsoft's Metaswitch to be Acquired by Alianza
Microsoft's Metaswitch to be Acquired by Alianza
Dec 10, 2024
11:09 AM EST, 12/10/2024 (MT Newswires) -- Microsoft's ( MSFT ) Metaswitch, a cloud-native communications software provider, is set to be acquired by cloud communications platform Alianza in a deal announced Tuesday. Financial terms of the agreement weren't disclosed. Alianza said the acquisition is set to close in Q1 2025. Price: 447.77, Change: +1.75, Percent Change: +0.39 ...
Update: Keyera Provides 2025 Capital Guidance, Three-Year Growth Strategy
Update: Keyera Provides 2025 Capital Guidance, Three-Year Growth Strategy
Dec 10, 2024
11:07 AM EST, 12/10/2024 (MT Newswires) -- (Adds analyst comment.) Keyera (KEY.TO) on Tuesday released its 2025 capital guidance and growth strategy for the three years to 2027. The oil and gas pipeline and processing company's growth capital expenditures are expected to range between $300 million and $330 million. Maintenance capital is projected at $70 million to $90 million. Growth...
Copyright 2023-2026 - www.financetom.com All Rights Reserved